B.Riley/FBR Downgrades Corcept Therapeutics (CORT) to Neutral

February 1, 2019 12:29 PM EST
Get Alerts CORT Hot Sheet
Price: $23.46 -1.43%

Rating Summary:
    9 Buy, 6 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 12 | Down: 28 | New: 29
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

B.Riley/FBR analyst David Buck downgraded Corcept Therapeutics (NASDAQ: CORT) from Buy to Neutral with a price target of $12.00.

For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.

Shares of Corcept Therapeutics closed at $11.18 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

David Buck